These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10652430)

  • 1. Losses of the tumor suppressor BIN1 in breast carcinoma are frequent and reflect deficits in programmed cell death capacity.
    Ge K; Duhadaway J; Sakamuro D; Wechsler-Reya R; Reynolds C; Prendergast GC
    Int J Cancer; 2000 Feb; 85(3):376-83. PubMed ID: 10652430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor.
    Sakamuro D; Elliott KJ; Wechsler-Reya R; Prendergast GC
    Nat Genet; 1996 Sep; 14(1):69-77. PubMed ID: 8782822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma.
    Ge K; DuHadaway J; Du W; Herlyn M; Rodeck U; Prendergast GC
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9689-94. PubMed ID: 10449755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
    Elliott K; Ge K; Du W; Prendergast GC
    Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of heterozygosity and tumor suppressor activity of Bin1 in prostate carcinoma.
    Ge K; Minhas F; Duhadaway J; Mao NC; Wilson D; Buccafusca R; Sakamuro D; Nelson P; Malkowicz SB; Tomaszewski J; Prendergast GC
    Int J Cancer; 2000 Apr; 86(2):155-61. PubMed ID: 10738240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bin1 mediates apoptosis by c-Myc in transformed primary cells.
    DuHadaway JB; Sakamuro D; Ewert DL; Prendergast GC
    Cancer Res; 2001 Apr; 61(7):3151-6. PubMed ID: 11306501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of estrogen sulfotransferase (EST) gene and bridging integrator protein-1 (BIN1) gene and their significance in breast tissues].
    Deng WH; Wu YY; Yang L; Tang WQ; Wang S
    Ai Zheng; 2004 Nov; 23(11):1302-5. PubMed ID: 15522178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the expression of Bin1, a putative suppressor, in human hepatoma cells.
    Livezey KW; Negorev D; Simon D
    Cancer Genet Cytogenet; 2000 Jan; 116(1):35-9. PubMed ID: 10616529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
    Hogarty MD; Liu X; Thompson PM; White PS; Sulman EP; Maris JM; Brodeur GM
    Med Pediatr Oncol; 2000 Dec; 35(6):559-62. PubMed ID: 11107117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis and differentiation in neuroblastoma and astrocytoma cells by the overexpression of Bin1, a novel Myc interacting protein.
    Galderisi U; Di Bernardo G; Cipollaro M; Jori FP; Piegari E; Cascino A; Peluso G; Melone MA
    J Cell Biochem; 1999 Sep; 74(3):313-22. PubMed ID: 10412034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
    J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bin1 functionally interacts with Myc and inhibits cell proliferation via multiple mechanisms.
    Elliott K; Sakamuro D; Basu A; Du W; Wunner W; Staller P; Gaubatz S; Zhang H; Prochownik E; Eilers M; Prendergast GC
    Oncogene; 1999 Jun; 18(24):3564-73. PubMed ID: 10380878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The putative tumor suppressor BIN1 is a short-lived nuclear phosphoprotein, the localization of which is altered in malignant cells.
    Wechsler-Reya R; Elliott K; Herlyn M; Prendergast GC
    Cancer Res; 1997 Aug; 57(15):3258-63. PubMed ID: 9242458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A structure-based model of the c-Myc/Bin1 protein interaction shows alternative splicing of Bin1 and c-Myc phosphorylation are key binding determinants.
    Pineda-Lucena A; Ho CS; Mao DY; Sheng Y; Laister RC; Muhandiram R; Lu Y; Seet BT; Katz S; Szyperski T; Penn LZ; Arrowsmith CH
    J Mol Biol; 2005 Aug; 351(1):182-94. PubMed ID: 15992821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of the human BIN1 gene. Evidence for tissue-specific transcriptional regulation and alternate RNA splicing.
    Wechsler-Reya R; Sakamuro D; Zhang J; Duhadaway J; Prendergast GC
    J Biol Chem; 1997 Dec; 272(50):31453-8. PubMed ID: 9395479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival.
    Ghaneie A; Zemba-Palko V; Itoh H; Itoh K; Sakamuro D; Nakamura S; Soler AP; Prendergast GC
    Cancer Biol Ther; 2007 Feb; 6(2):192-4. PubMed ID: 17218774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
    Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
    Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The murine Bin1 gene functions early in myogenesis and defines a new region of synteny between mouse chromosome 18 and human chromosome 2.
    Mao NC; Steingrimsson E; DuHadaway J; Wasserman W; Ruiz JC; Copeland NG; Jenkins NA; Prendergast GC
    Genomics; 1999 Feb; 56(1):51-8. PubMed ID: 10036185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
    Han Y; San-Marina S; Yang L; Khoury H; Minden MD
    Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.